Clinical Scorecard: Assessment of Persistent Pain Prevalence and Features in Survivors of Head and Neck Cancer: A Systematic Review and Meta-Analysis
At a Glance
Category
Detail
Condition
Persistent pain in head and neck cancer survivors
Key Mechanisms
Nociceptive, neuropathic, and nociplastic pain mechanisms; altered pain processing with hypersensitivity and hyperalgesia
Target Population
Survivors of head and neck cancer who completed treatment at least 3 months prior
Care Setting
Post-cancer treatment survivorship care
Key Highlights
Approximately 31% of head and neck cancer survivors experience persistent pain after treatment completion.
Pain phenotypes include craniofacial, cervicogenic, jaw bone pain, myofascial orofacial pain, and trigeminal neuralgia.
Persistent pain is multifactorial, influenced by cancer treatment sequelae and altered nociceptive processing.
Guideline-Based Recommendations
Diagnosis
Assess pain presence at least 3 months post-treatment to identify persistent pain.
Evaluate pain phenotypes considering nociceptive, neuropathic, and nociplastic mechanisms.
Use validated pain measurement methods acknowledging variability in assessment timing.
Management
Tailor therapeutic approaches to specific pain mechanisms due to differing pathophysiology.
Address biological factors and psychological symptoms associated with persistent pain.
Consider multidisciplinary interventions to manage complex pain profiles.
Monitoring & Follow-up
Regularly monitor pain intensity and characteristics during survivorship care.
Assess for changes in pain phenotype and impact on activities of daily living.
Evaluate psychological status and pain-related disability over time.
Risks
Persistent pain may worsen psychological symptoms and functional disability.
Chronic mucositis is a risk factor for ongoing pain.
Heterogeneity in cancer location, treatment type, and assessment methods complicate risk stratification.
Patient & Prescribing Data
Head and neck cancer survivors post-treatment
Pain management requires mechanism-specific therapies; current data highlight a need for individualized approaches due to diverse pain phenotypes and multifactorial etiology.
Clinical Best Practices
Implement systematic pain assessments in head and neck cancer survivorship programs.
Recognize and differentiate pain phenotypes to guide targeted treatment.
Incorporate multidisciplinary care addressing both physical and psychological aspects of persistent pain.
by Miguel Ángel Fernández-Gualda, Paula Postigo-Martin, Maria Fernandez-Gonzalez, Lydia Martin-Martin, Pilar Vargas-Arrabal, Mario Lozano-Lozano, Carolina Fernández-Lao
